Lifestyle Drugs Require High Copay Differentials to Curb Use, PBM Exec Says
A high level of cost sharing is necessary to discourage non-essential use of drugs, Catalyst Rx President Kevin Hooks said
You may also be interested in...
Medicare Part D is giving drug plans an opportunity to use more restrictive pharmacy benefit designs that had previously not been palatable to the commercial sector
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011